Heart Disease Trial, Recruiting (NCT04113356)

Heart Disease Trial, Recruiting NCT04113356 Sponsor: Medical University Innsbruck Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04113356 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had their first-ever heart attack of a specific type (called an ST-elevation myocardial infarction, or STEMI), diagnosed using standard international medical guidelines
People who received an emergency procedure to open a blocked heart artery (called a primary PCI, where a small tube is inserted to restore blood flow) within 24 hours of their symptoms starting

Who may not be able to join:

People under 18 years of age
People who have previously had a heart attack or any procedure to treat blocked heart arteries
People whose heart condition is considered severely unstable at the time of the trial (classified as Killip class 3 or higher — confirm with trial site)
People with serious kidney problems, where the kidneys are not filtering blood well enough (confirm with trial site)
People who cannot have an MRI heart scan, which includes those with a pacemaker, a metal clip in the brain, a metal fragment in or near the eye, a known or suspected allergy to the MRI contrast dye (gadolinium), or severe claustrophobia (fear of enclosed spaces)
People who are unable to give their own informed consent to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04113356

Sponsor: Medical University Innsbruck

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

More information: https://clinicaltrials.gov/study/NCT04113356

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had their first-ever heart attack of a specific type (called an ST-elevation myocardial infarction, or STEMI), diagnosed using standard international medical guidelines
People who received an emergency procedure to open a blocked heart artery (called a primary PCI, where a small tube is inserted to restore blood flow) within 24 hours of their symptoms starting

Who may not be able to join:

People under 18 years of age
People who have previously had a heart attack or any procedure to treat blocked heart arteries
People whose heart condition is considered severely unstable at the time of the trial (classified as Killip class 3 or higher — confirm with trial site)
People with serious kidney problems, where the kidneys are not filtering blood well enough (confirm with trial site)
People who cannot have an MRI heart scan, which includes those with a pacemaker, a metal clip in the brain, a metal fragment in or near the eye, a known or suspected allergy to the MRI contrast dye (gadolinium), or severe claustrophobia (fear of enclosed spaces)
People who are unable to give their own informed consent to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical University Innsbruck

Registry

ClinicalTrials.gov

Start date

1 January 2011

Est. completion

1 June 2026

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Occurence of major adverse cardiovascular events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov